Physician profile
John Collier
NPI 1649229741
$1,702.50
in general payments reported to CMS, 2019-2025
18 companies · $302 in 2025
The $302 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2021: $221 · 2022: $204 · 2023: $467 · 2024: $272 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,041.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $318.47 | 2019-2023 | Breztri |
| Inspire Medical Systems, INC. | $252.68 | 2024-2025 | Inspire |
| United Therapeutics Corporation | $182.98 | 2021-2022 | |
| Boston Scientific Corporation | $156.94 | 2025 | Enroute Transcarotid Neuroprotection System |
| Mirum Pharmaceuticals, INC. | $150.00 | 2024 | Livmarli |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.32 | 2019 | |
| Noah Medical Corporation | $92.49 | 2023 | |
| Intuitive Surgical, INC. | $80.31 | 2023 | Da Vinci Surgical System |
| Pulmonx Corporation | $76.40 | 2021 | |
| Inogen, INC. | $50.18 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Exelixis INC. | $50.00 | 2021 | |
| Grifols USA, LLC | $40.31 | 2022-2023 | Prolastin-C Liquid |
| Paratek Pharmaceuticals, INC. | $33.22 | 2023 | Nuzyra |
| Incyte Corporation | $31.54 | 2022 | |
| Celgene Corporation | $23.89 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $22.38 | 2022 | |
| Genentech USA, INC. | $21.10 | 2022 | |
| Allergan, INC. | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Collier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.